Clinical Trial Update: Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating early ablation therapy for ischemic ventricular tachycardia in patients with implantable cardioverter-defibrillators was terminated. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Ventricular Tachycardia

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Ventricular Tachycardia, Ischemic | Phase 4 | Status: TERMINATED | Results posted: 2015-01-01